口腔癌に対する制癌剤の動脈内挿管注入法の臨床的, ならびに実験的研究
スポンサーリンク
概要
- 論文の詳細を見る
Administration of anti-cancer drugs for oral cancer may be restricted within the area of adjuvant therapy. There is, however, no doubt that it is an important method next to operation and irradiation. In treating oral cancers in our department since 1964, we have been testing a therapy plan, in which intra-arterial infusion through the arteria temporalis superficialis of the affected side preceeds, and operation and/or irradiation follows depending of the case. The author have studied the fifty-three cases treated by intra-arterial infusion of various drugs in the Second Department of Oral Surgery, Kyushu Dental College, between 1964 and 1969. The author has studied the correlation between the treatment method and the result ; the clinical findings at the first examination and the findings of the pathological examinations of the samples of small tissue section and the treatment result. In addition, experimental oral cancer was created by transplanting Vx2 carcinoma in the buccal masticatory muscles of rabbits and anti-cancer drugs (MT-C or BLM) were intra-arterially infused. As a result of histopathological examinations of the effect, the following conclusions were obtained. I. Clinical study a. The approximate survival rate of the 53 cases of intra-arterial infusion was 35.3%. (33.3% for single treatment group by intra-arterial infusion and 40.0% for combined treatment group). The treatment results obtained were better than those reported by others. Significance of our therapy plan was thus proved. The combined treatment method of intra-arterial infusion followed by surgery or irradiation, in particular, was superior in the treatment results. b. Comparative studies by treatment method was undertaken of the treatment result, the occurrence sites, the clinical findings of clinical progress, the histological type by the samples of small tissue sections for pathological diagnosis, the architecure of cancerous parenchyme, histopathological findings of stroma reactions. As a result, it was indicated that the combined treatment method, when compared with the single treatment, excelled somewhat in the treatment results. c. Significance of selective administration of a suitable, anti-cancer drug by screening test was recognized. Furthermore, the fact that better treatment results were obtained in the cases treated by the combined method in addition to the selective administration is indicative of direction for treating oral cancers. II. Experimental Study a. The transplanted tumors gradually developed daily, and reached the size of a child's fist by thirty days after transplantation. b. Comparing with the control group, a restriction in the growth was clearly observed in the experiment groups and the tumors were smaller than those of the control group. c. No distinct difference in the sizes of tumors was observed between the MT-C administered group and the BLM administered group of the experiment groups. d. With an increase in the number of administration, compared with the control group, degenerative changes such as concentration swelling, disintegration and decrease in sensetivity to staining of the nucleus and vacuolation of cytoplasma, were observed clearly. No distinct difference in such changes was observed between the MT-C administered group and the BLM administered group. e. MT-C administered group showed a somewhat stronger trend for fibrosis of the valamentum than BLM administered group. No distinct difference in fibrous stroma reactions and cellular stroma reactions was observed between the MT-C administered group and the BLM administered group.
- 九州歯科学会の論文
- 1974-07-31
著者
関連論文
- 1. 上顎癌早期発見に関する実験的, 病態生化学的研究(一般講演抄録)
- 22. 口腔癌化学療法における生検材料と治療効果の相関について(第 28 回九州歯科学会総会ならびに学術講演会)
- 40. 骨創腔処理にあたっての Freeze-Dried Bone の応用(第 30 回九州歯科学会総会ならびに学術講演会)
- 57. "いわゆる油症" 2 例の口腔所見について(第 29 回九州歯科学会総会ならびに学術講演会)
- 27. 制癌剤の感受性に関する研究 : Screening test(S.D.I., I.N.K. 法)に基づく Mitomycin C の動注成績について(第 28 回九州歯科学会総会ならびに学術講演会)
- 口腔癌に対する Bleomycin の臨床応用経験
- 培養細胞による X 線・制癌剤の併用効果についての検討 : (第 1 報)5-Fluorouracil, Mitomycin C について
- 8. 培養細胞による X 線・制癌剤の併用効果についての検討(第 1 報)(6 月例会, 九州歯科学会)
- 7. 口腔癌および口腔領域各種疾患における血清乳酸脱水素酵素活性についての検討(6 月例会, 九州歯科学会)
- 口腔癌および口腔領域各種疾患における血清乳酸脱水素酵素活性値についての検討
- 脂肪腫の 2 例
- 25. 口腔癌化学療法に際し、S.D.I. 法の追試経験(第 26 回 九州歯科学会総会講演抄録)
- 非ステロイド性抗炎症剤 Riripen の顎・口腔領域における臨床使用経験
- 口腔癌に対する制癌剤の動脈内挿管注入法の臨床的ならびに実験的研究 : 主論文の要旨
- 35. 口腔癌および口腔領域各種疾患における血清糖蛋白について(一般講演抄録)
- 口腔癌に対する制癌剤の動脈内挿管注入法の臨床的, ならびに実験的研究
- 14. 口腔癌化学療法における生検材料と薬剤効果の関係について
- 31. 口腔癌に対する PC-B-45 の使用経験(第 32 回九州歯科学会総会報告)
- 巨大なる骨線維腫性エプーリスの 1 例
- 65. Kuttner 病(Kuttner 腫瘍)の 1 治験例(第 28 回九州歯科学会総会ならびに学術講演会)
- 口腔外科全身麻酔患者における麻酔中体温変化に関する研究(第 1 報)
- 比較的大きな鼻口蓋管嚢胞の一治験例
- 制癌剤の感受性に関する研究 : 3. 制癌剤感受性試験としての I.N.K. 法、S.D.I. 法の一致性について
- 制癌剤の感受性に関する研究 : 1. 口腔癌化学療法に際し、制癌剤感受性試験としての I.N.K. 法の追試経験
- 顎下部及び下口唇部にみられた所謂重複癌の一例
- 先天性下唇瘻の2例
- 油症 (塩化ビフェニール中毒症) 2例の口腔所見について
- 歯肉線維腫症の電子顕微鏡学的観察